STAT+: Sanofi, Regeneron expand partnership after Dupixent success
Sanofi and Regeneron Pharmaceuticals, the duo behind the hugely successful drug Dupixent, are re-upping their partnership, with the companies announcing Thursday an expanded collaboration on a new series of antibodies for immunological diseases. As…
ImpactNotable 33/100
Why it mattersRule-based estimate: no strong signals; trust 8/10.
RegionsGlobal
Published6 h ago (Thu, 01 Oct 2026 06:16:27 GMT)
RetrievedThu, 01 Oct 2026 09:00:53 GMT via rss
ClassifiedThu, 01 Oct 2026 09:01:06 GMT by heuristic
AuthorAndrew Joseph